ArticleAnnals of medicine2021

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.

Liye Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.